Zhong Jin Zai Xian·2026-01-15 06:53Core Insights - Yunnan Baiyao Group's subsidiary, Guoyao Innovation, launched the proprietary traditional Chinese medicine product "Shulianan® Shulianan Capsules" on JD Health, targeting chronic non-bacterial prostatitis in men suffering from lower urinary tract symptoms [1][4] - The product aims to address the high prevalence of chronic prostatitis, particularly in men aged 30-39 and 60-69, where the incidence rates are 34.4% and 36.4% respectively [3] - The launch reflects Yunnan Baiyao's commitment to the "Healthy China" strategy and its focus on providing effective health solutions, showcasing its strategy of "big products + secondary development" [4] Product Details - Shulianan Capsules are derived from the traditional Yi medicine "Song Lou Zheng" and utilize the single herb "Da Fa Biao" to treat symptoms such as frequent urination, urgency, and pain associated with chronic non-bacterial prostatitis [3] - The development of Shulianan Capsules is based on modern pharmacology and clinical evaluation, validating its efficacy through systematic pharmacological and clinical research [3] Strategic Collaboration - The launch on JD Health represents a deepening of the strategic partnership established in April 2025, focusing on supply chain, retail, and innovative marketing collaboration [4] - JD Health will leverage its full-channel network to enhance the product's accessibility, integrating online consultations and patient education to create a comprehensive management experience [4] - Future initiatives will explore digital marketing, patient education projects, and the integration of online and offline services to develop a user-centered chronic disease management ecosystem [4]